Specialty code 183500000X · Vacaville, CA
NPI
1255424222
Since 2006
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1 Quality Dr, Medicine
Vacaville, CA, 95688
Phone (707) 624-2012
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$366K
2,109 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Christy J Yee prescribed most often to Medicare patients was Atorvastatin Calcium, with 238 prescriptions and refills. In total Christy J Yee wrote 2,109 Medicare prescriptions that cost $366K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-09-23.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 238 | 793 | 83 | $3,000 |
| Metformin Hcl Er Metformin Hcl | 223 | 725 | 90 | $2,267 |
| Glipizide Generic | 164 | 531 | 62 | $1,837 |
| Jardiance Empagliflozin | 142 | 457 | 49 | $73K |
| Ozempic Semaglutide | 129 | 133 | 27 | $95K |
| Humulin N Insulin Nph Human Isophane | 105 | 308 | 53 | $18K |
| Insulin Glargine-Yfgn Generic | 104 | 300 | 55 | $15K |
| Metformin Hcl Generic | 94 | 311 | 37 | $1,270 |
| Victoza 2-Pak Liraglutide | 91 | 91 | 19 | $57K |
| Humulin R Insulin Regular, Human | 91 | 264 | 29 | $12K |
| Veo Insulin Syringe Syringe-Needle,insulin,0.5 Ml | 77 | 250 | 36 | $2,004 |
| Lisinopril Generic | 65 | 217 | 23 | $829 |
| Simvastatin Generic | 52 | 173 | 20 | $607 |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 51 | 144 | 23 | $1,103 |
| Pioglitazone Hcl Generic | 48 | 160 | 16 | $567 |
Brand drugs: 811 claims; generic drugs: 1,099 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Christy J Yee were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.